Sponsor:
UCLA
Code:
NCT06831929
Conditions
HPV Vaccine
Eligibility Criteria
Sex: All
Age: 10 - 12
Healthy Volunteers: Accepted
Interventions
Intervention Arm
Brief summary:
Conditions
HPV Vaccine
Study ID
NCT06831929
Start date
Feb 28, 2025
Status verified date
Aug, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Feb 5, 2026
Eligibility Criteria
Sex: All
Age: 10 - 12
Healthy Volunteers: Accepted
Enrollment
2232 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
no intervention: Control Arm
experimental: Intervention Arm
Interventions
Intervention Arm
Primary outcome measure
Central contacts
Locations
University of California Davis Health
Recruiting
Sacramento, California, United States, 95817
Contacts
Julie HT Dang, PhD
jtdang@ucdavis.eduSponsor
University of California, Davis
Last update posted
Aug 11, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, Davis on 2026-08-11.